These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1829974)

  • 41. The effect of dopamine on rat gastric motility.
    Nagahata Y; Urakawa T; Kuroda H; Tomonaga K; Idei H; Kawakita N; Yoshizumi K; Saitoh Y
    Gastroenterol Jpn; 1992 Aug; 27(4):482-7. PubMed ID: 1356091
    [TBL] [Abstract][Full Text] [Related]  

  • 42. D-1 dopamine receptors mediate dopamine-induced pancreatic exocrine secretion in anesthetized dogs.
    Iwatsuki K; Horiuchi A; Ren LM; Chiba S
    Hypertens Res; 1995 Jun; 18 Suppl 1():S173-4. PubMed ID: 8529053
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Opposite effects of neurotensin on dopamine inhibition in different regions of the rat brain: an iontophoretic study.
    Beauregard M; Ferron A; Descarries L
    Neuroscience; 1992; 47(3):613-9. PubMed ID: 1350070
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of selective dopamine D2-receptor agonists on the release of cholecystokinin-like immunoreactivity from rat neostriatum.
    Conzelmann U; Holland A; Meyer DK
    Eur J Pharmacol; 1984 May; 101(1-2):119-25. PubMed ID: 6235119
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Altered responsiveness of regional brain dopamine and DOPAC levels to systemic administration of quinpirole, a dopamine D2 agonist, in DOCA/NaCl-hypertensive rats.
    Chen YF; Jin HK; Gist R; Oparil S
    Brain Res; 1987 Jun; 413(1):15-22. PubMed ID: 2954616
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential visualization of dopamine D2 and D3 receptors in rat brain.
    Parsons B; Stanley M; Javitch J
    Eur J Pharmacol; 1993 Apr; 234(2-3):269-72. PubMed ID: 8097723
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dopamine receptors, controlling dopamine levels in rat adrenal glands-comparison with central dopaminergic autoreceptors.
    Kujacic M; Svensson K; Löfberg L; Carlsson A
    J Neural Transm Gen Sect; 1991; 84(3):195-209. PubMed ID: 1679336
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dopamine receptors and hypertension. Physiologic and pharmacologic implications.
    Goldberg LI
    Am J Med; 1984 Oct; 77(4A):37-44. PubMed ID: 6148892
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modulation of dopamine metabolism in the retina via dopamine D2 receptors.
    Hadjiconstantinou M; Krajnc D; Rossetti Z; Neff NH
    Brain Res; 1990 Nov; 533(1):20-3. PubMed ID: 2150768
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The dopamine D2 receptor agonists, quinpirole and bromocriptine produce conditioned place preferences.
    Hoffman DC; Dickson PR; Beninger RJ
    Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(2-3):315-22. PubMed ID: 2968613
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evidence for an increased catecholamine synthesis in rat adrenal glands following stimulation of peripheral dopamine receptors.
    Kujacic M; Carlsson A
    J Neural Transm Gen Sect; 1993; 92(2-3):73-9. PubMed ID: 8103662
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Involvement of dopamine receptor subtypes in dopaminergic modulation of aldosterone secretion in rats.
    Barrett RJ; Wright KF; Taylor DR; Proakis AG
    Life Sci; 1987 Apr; 40(15):1499-506. PubMed ID: 2951574
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 2-phenylethylamine and methamphetamine enhance the spinal monosynaptic reflex by releasing noradrenaline from the terminals of descending fibers.
    Ono H; Ito H; Fukuda H
    Jpn J Pharmacol; 1991 Mar; 55(3):359-66. PubMed ID: 1830350
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neural development is regulated by classical neurotransmitters: dopamine D2 receptor stimulation enhances neurite outgrowth.
    Todd RD
    Biol Psychiatry; 1992 Apr; 31(8):794-807. PubMed ID: 1643194
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increased sensitivity of rabbit carotid body chemoreceptors to dopamine after chronic treatment with domperidone.
    McQueen DS; Mir AK; Brash HM; Nahorski SR
    Eur J Pharmacol; 1984 Sep; 104(1-2):39-46. PubMed ID: 6499917
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Is domperidone a selective peripheral dopamine-receptor antagonist in vivo?
    Arnerić SP; Collins ED; Bhatnagar RK; Long JP
    Neuropharmacology; 1982 Dec; 21(12):1317-21. PubMed ID: 7155311
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dopaminergic and ligand-independent activation of steroid hormone receptors.
    Power RF; Mani SK; Codina J; Conneely OM; O'Malley BW
    Science; 1991 Dec; 254(5038):1636-9. PubMed ID: 1749936
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pressor responses to brain dopaminergic stimulation.
    van den Buuse M
    Clin Exp Pharmacol Physiol; 1997; 24(9-10):764-9. PubMed ID: 9315386
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Observations on dopamine receptor antagonists and gastric ulceration associated with experimental anorexia cachexia.
    Willis GL; Sleeman M; Brodie G; Smith GC
    Pharmacol Biochem Behav; 1988 Sep; 31(1):69-73. PubMed ID: 3252263
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Separation of dopamine D1 and D2 receptors.
    Dumbrille-Ross A; Niznik H; Seeman P
    Eur J Pharmacol; 1985 Mar; 110(1):151-2. PubMed ID: 3159588
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.